Targeted replacement of human γδ TCR in mice enhances antigen-specific B cell immunity - Report - MDSpire

Targeted replacement of human γδ TCR in mice enhances antigen-specific B cell immunity

  • By

  • Husheem Michael

  • Michael Pitre

  • Gene W. Weng

  • Mikaela M. Vallas

  • Ellen Chen

  • Paul Sheiffele

  • Wei Weng

  • June 17, 2026

  • 0 min

Share

Enhanced Antigen-Specific B Cell Responses in Mice with Human γδ T Cell Receptor Replacement

Overview

This study demonstrates that γδ HuTCR-T1 mice exhibit significantly enhanced B cell activity and a distinct cytokine profile following immunization with collagen and keratin antigens. The findings suggest that human γδ T cells play a crucial role in modulating adaptive and humoral immunity.

Background

Understanding the interactions between B cells and γδ T cells is essential for advancing immunotherapy and vaccine development. γδ T cells provide critical support to B cells, influencing their maturation and antibody production. The γδ HuTCR-T1 mouse model offers a valuable platform for studying human-like immune responses, bridging the gap between traditional animal models and human clinical studies.

Data Highlights

No numerical data available in the provided material.

Key Findings

  • γδ HuTCR-T1 mice showed a significant increase in antigen-specific antibody-secreting cells (ASCs).
  • Elevated serum levels of antigen-specific IgG, IgA, and IgE were observed in γδ HuTCR-T1 mice.
  • Expansion of plasma and memory B cell populations was noted in the spleen and blood of γδ HuTCR-T1 mice.
  • A distinct cytokine profile was identified, with increased production of IL-4, IL-6, IL-10, IL-17, TGFβ, IFNγ, and TNFα.
  • Serum levels of anti-ANA antibodies remained below detection thresholds in γδ HuTCR-T1 mice.

Clinical Implications

The findings underscore the potential of targeting γδ T cells to enhance B cell responses in therapeutic settings. This model may facilitate the development of new immunotherapies and vaccines by providing insights into human immune dynamics.

Conclusion

The study highlights the critical role of human γδ T cells in regulating B cell responses and establishes the γδ HuTCR-T1 mouse model as a significant resource for preclinical research in immunology.

Related Resources & Content

  1. The Journal of Infectious Diseases, 2023 -- A Transgenic Mouse With a Humanized B-Cell Repertoire Mounts an Antibody Response to Influenza Infection and Vaccination
  2. Bone Marrow Transplantation, 2021 -- Depletion of CD276+ Cells from Haploidentical Memory T-Cell Grafts Reduces GVHD Risk
  3. Bone Marrow Transplantation, 2015 -- Investigating Gender Differences in Human T-cell Reconstitution Following Cord Blood Stem Cell Transplantation in Humanized Mice
  4. EULAR recommendations for the management of rheumatoid arthritis with synthetic and biologic disease-modifying antirheumatic drugs: 2025 update - ScienceDirect
  5. Collagen-Induced Arthritis Models - PubMed
  6. Blood Cancer Journal — Exposure to Systemic TLR2 Agonists Modulates Hematopoietic Stem Cell Activity Through Both Autonomous and Non-Autonomous Pathways
  7. Phosphoantigen recognition by Vγ9Vδ2 T cells - Herrmann - 2024 - European Journal of Immunology
  8. What We Know and What We Don't Know About the Function of γδ T Cells
  9. EULAR recommendations for the management of rheumatoid arthritis with synthetic and biologic disease-modifying antirheumatic drugs: 2025 update - ScienceDirect
  10. EULAR recommendations for the management of rheumatoid arthritis with synthetic and biologic disease-modifying antirheumatic drugs: 2025 update - University of Lisbon
  11. Collagen-Induced Arthritis Models - PubMed
  12. INB-200: Fully enrolled phase 1 study of gene-modified autologous gamma-delta (γδ) T cells in patients with newly diagnosed glioblastoma multiforme (GBM) receiving maintenance temozolomide (TMZ). | Journal of Clinical Oncology
  13. COVID‐19 Vaccination Before Initiating Rituximab Treatment Induces Strong Serological Response in Autoimmune Rheumatic Disease, Reducing Post‐Pandemic Concerns About the Impact of Rituximab - Ammitzbøll - 2024 - ACR Open Rheumatology - Wiley Online Library
  14. Advisory Committee on Immunization Practices Recommended Immunization Schedule for Adults Aged 19 Years or Older — United States, 2025 | MMWR
  15. Effect of methotrexate hold on COVID-19 vaccine response in the patients with autoimmune inflammatory disorders: a systematic review and meta-analysis - PubMed
  16. Targeting the Neonatal Fc Receptor in Autoimmune Diseases: Pipeline and Progress | BioDrugs | Springer Nature Link

Original Source(s)

Related Content